Literature DB >> 14527614

The effect of acetazolamide on the changes of cerebral blood flow and oxygen metabolism during visual stimulation.

Hiroshi Yamauchi1, Hidehiko Okazawa, Yoshihiko Kishibe, Kanji Sugimoto, Masaaki Takahashi.   

Abstract

Acetazolamide, a carbonic anhydrase inhibitor, has an anticonvulsant effect which may result from a decrease in the efficacy of synaptic transmission due to a decrease of pH. Our previous study showed that acetazolamide induced a significant increase in global and regional cerebral blood flow (CBF), but caused no significant change in the cerebral metabolic rate of oxygen (CMRO(2)). To investigate the effect of acetazolamide on the responses of CBF and CMRO(2) during neural stimulation, we used positron emission tomography to measure CBF and CMRO(2) in six normal volunteers at the fixation-only baseline visual state and during visual stimulation before and after administration of 1 g of acetazolamide. Visual stimulation induced a significant increase in CBF (33%) in the visual cortex compared with baseline values, but caused no significant change in CMRO(2), while no significant change in global CBF or CMRO(2) was found. During visual stimulation after acetazolamide administration, both global and visual cortical CBF and CMRO(2) showed similar changes compared with the respective baseline values (37 and 65% increases in CBF and 8 and 16% decreases in CMRO(2), respectively). When corrected by the global values, the magnitudes of the CBF and CMRO(2) responses to visual stimulation after acetazolamide administration were less than those before (20% vs 38% in CBF and -9% vs 3% in CMRO(2)). Considering our previous observation that the effect of acetazolamide was similar throughout cerebral cortical regions, we suggest that acetazolamide decreases the responses of both CBF and CMRO(2) during visual stimulation, which indicates that this drug may affect neuronal excitability.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14527614     DOI: 10.1016/s1053-8119(03)00283-0

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  6 in total

1.  Neuronal activation induced BOLD and CBF responses upon acetazolamide administration in patients with steno-occlusive artery disease.

Authors:  Jeroen C W Siero; Nolan S Hartkamp; Manus J Donahue; Anita A Harteveld; Annette Compter; Esben T Petersen; Jeroen Hendrikse
Journal:  Neuroimage       Date:  2014-09-26       Impact factor: 6.556

2.  Acetazolamide during acute hypoxia improves tissue oxygenation in the human brain.

Authors:  Kang Wang; Zachary M Smith; Richard B Buxton; Erik R Swenson; David J Dubowitz
Journal:  J Appl Physiol (1985)       Date:  2015-10-15

Review 3.  New insights into carbonic anhydrase inhibition, vasodilation, and treatment of hypertensive-related diseases.

Authors:  Erik R Swenson
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

4.  Does baseline cerebral blood flow affect task-related blood oxygenation level dependent response in schizophrenia?

Authors:  Jiacheng Liu; Maolin Qiu; R Todd Constable; Bruce E Wexler
Journal:  Schizophr Res       Date:  2012-07-11       Impact factor: 4.939

5.  Quantifying the changes in oxygen extraction fraction and cerebral activity caused by caffeine and acetazolamide.

Authors:  Sagar Buch; Yongquan Ye; E Mark Haacke
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-21       Impact factor: 6.200

6.  Quantitative Distribution of Cerebral Venous Oxygen Saturation and Its Prognostic Value in Patients with Acute Ischemic Stroke.

Authors:  Fengqiu Cao; Mingming Wang; Shanhua Han; Shengyu Fan; Yingwei Guo; Yingjian Yang; Yu Luo; Jia Guo; Yan Kang
Journal:  Brain Sci       Date:  2022-08-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.